Molecular and Clinical Biology of von Willebrand Disease Study

Clinical Trial Title

Molecular and clinical biology of von Willebrand disease.

Clinical Trial Protocol Description:

This research study will compare bleeding symptoms (or lack of bleeding symptoms) to each of the following:

  1. Routine laboratory tests used to diagnosed von Willebrand disease (VWD).
  2. New genetic or specialized tests of how von Willebrand Factor (VWF) works.
  3. Determine if other genes or proteins might cause you to have (or not have) bleeding symptoms or abnormal VWD laboratory tests results.

The study will also verify if patients have VWD.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Have VWD.
  • Are at least 2 years of age.

This is a partial list of elgibility requirements.

Study Details

Clinical Trial Investigator

Lisa Boggio, MD

Contact Information

Lisa Boggio, MD

(312) 942-3034